Appili Therapeutics is an anti-infective pharmaceutical development company.
Appili Therapeutics is an anti-infective pharmaceutical development company. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 7, 2018 | Seed | $4.33M | 1 | Innovacorp | — | Detail |
Oct 23, 2017 | Seed | $3.06M | 1 | Innovacorp | — | Detail |
Dec 21, 2016 | Seed | $2.15M | 1 | Innovacorp | — | Detail |
May 25, 2016 | Seed | $3.30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Innovacorp | Yes | Seed |